French public support cost-cutting measures:
This article was originally published in Clinica
Executive Summary
Around 90% of French people support the strict cost-cutting measures employed to control social security and health spending. However, over half of respondents in a survey carried out by IPSOS in the French weekly, Le Point, claimed reimbursement for health products was worse than ten years ago. A quarter of those questioned claimed to have abandoned dental care due to cost. Eye inspections and specialist medical examinations were relinquished by 15% and 18% of people respectively due to cost. The survey was carried out in June and involved over 1,000 people.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.